Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

PRECIOUS-Gold hits one-week high on muted dollar, U.S. stimulus hopes

Published 02/12/2020, 10:02 pm
Updated 02/12/2020, 11:12 pm
XAU/USD
-
XAG/USD
-
GC
-
SI
-
PA
-
PL
-

(Updates prices)

* Britain approves Pfizer-BioNTech's COVID-19 vaccine

* Interactive graphic tracking global spread of coronavirus: open

* https://tmsnrt.rs/3aIRuz7 in an external browser

By Eileen Soreng

Dec 2 (Reuters) - Gold rose to over a one-week high on Wednesday supported by a soft dollar, while signs of progress in discussions over a new U.S. coronavirus relief package bolstered bullion's appeal as a hedge against possible inflation.

Top Senate Republican Mitch McConnell urged the U.S. Congress to pass a $1.4 trillion spending bill including coronavirus stimulus, while some senators and House members proposed relief measures worth $908 billion. gold XAU= rose 0.6% to $1,825.41 per ounce by 1200 GMT, having earlier hit $1,832.20, its highest since Nov. 24.

U.S. gold futures GCv1 gained 0.6% to $1,829.30.

"There's a risk that you could get a little bit of inflation... There is a good possibility we will retest $1,835- $1,836 level," said Michael Hewson, chief market analyst at CMC Markets UK.

However, more positive vaccine news could push more money out of gold and into riskier assets, Hewson added.

Making bullion cheaper for holders of other currencies, the dollar steadied off a low since April 2018. USD/

Near-zero interest rates and unprecedented stimulus to revive the global economy have driven gold about 20% higher so far in 2020, since the non-yielding asset is considered a hedge against likely inflation and currency debasement.

Gold, however, marked its worst monthly performance in four years in November hit by optimism over vaccine-led economic recovery.

Britain became the first country in the world on Wednesday to approve Pfizer-BioNTech's vaccine. will be a mixed year for gold, positive in the first half and negative in the second, said UBS analyst Giovanni Staunovo.

"Essentially it's driven by the vaccine use influencing central bank activity ... I'm not saying there will be a rate cut, but there'll be some discussion about a change in the policy environment and gold will start to feel the pain (in the second half)," he said.

Elsewhere, silver XAG= rose 0.4% to $24.10 per ounce. Platinum XPT= rose 1% to $1,009.47 and palladium XPD= eased 0.2% to $2,402.46.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.